Paremyd
Product Images NDC 17478-704

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Paremyd (NDC 17478-704). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Akorn, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Par02 0003 01

Chemical structure diagram showing two compounds: hydrobromide salt of hydroxyamphetamine and tropicamide. The structures include chemical groups and bonds as typically depicted in molecular diagrams, representing the active ingredients.*

FDA Label Image

Par02 0003 02

Label for Paremyd (hydroxyamphetamine hydrobromide/tropicamide ophthalmic solution) 1%/0.25% by Akorn, Inc. The label indicates a sterile 15 mL solution for prescription use only, including active ingredients, preservative, inactives, dosage reference, storage instructions, and manufacturer details.*

FDA Label Image

Par02 0003 03

Packaging label for Paremyd ophthalmic solution by Akorn, showing active ingredients hydroxyamphetamine hydrobromide 1.0% and tropicamide 0.25% in a 15 mL sterile bottle. The label includes directions to see package insert for dosage, storage instructions at 20° to 25°C, and a list of inactive ingredients. The label also features the Akorn logo, NDC 17478-704-12, and barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.